Research Programs Unit, Molecular Medicine, University of Helsinki, Helsinki, Finland.
PLoS One. 2013;8(2):e56825. doi: 10.1371/journal.pone.0056825. Epub 2013 Feb 14.
Pompe disease is a recessively inherited and often fatal disorder caused by the deficiency of acid α-glucosidase, an enzyme encoded by the GAA gene and needed to break down glycogen in lysosomes. This glycogen storage disease type II has been reported also in Swedish Lapphund dogs. Here we describe the genetic defect in canine Pompe disease and show that three related breeds from Scandinavia carry the same mutation. The affected dogs are homozygous for the GAA c.2237G>A mutation leading to a premature stop codon at amino acid position 746. The corresponding mutation has previously been reported in humans and causes infantile Pompe disease in combination with a second fully deleterious mutation. The affected dogs from both the Finnish as well as the Swedish breed mimic infantile-onset Pompe disease genetically, but also clinico-pathologically. Therefore this canine model provides a valuable tool for preclinical studies aimed at the development of gene therapy in Pompe disease.
庞贝病是一种常染色体隐性遗传性疾病,通常是致命的,由酸性α-葡萄糖苷酶(GAA)缺乏引起,GAA 是一种溶酶体中分解糖原所必需的酶,由 GAA 基因编码。这种糖原贮积病Ⅱ型也见于瑞典拉普杭犬。本研究描述了犬庞贝病的遗传缺陷,并证实来自斯堪的纳维亚的 3 个相关品种携带相同的突变。受影响的犬只 GAA c.2237G>A 突变纯合子,导致第 746 位氨基酸提前出现终止密码子。该突变已在人类中报道,与另一个完全有害的突变共同导致婴儿型庞贝病。来自芬兰和瑞典品种的受影响犬只在遗传和临床病理上均模拟婴儿型庞贝病。因此,这种犬模型为旨在开发庞贝病基因治疗的临床前研究提供了有价值的工具。